Thursday, 29 January 2009
CLINUVEL Pharmaceuticals is set to begin clinical trials of its prophylactic skin treatment, afamelanotide, in the United States after the company got the go-ahead from the US Food and Drug Administration.
You are not logged in or not authorised to view this page.
Get Your FREE 30 Day Trial Now!
|
|
|
OR
Click here to read the rest of today's news stories.
|